Genetics

A paper co-authored by Kristin Comella’s, chief science officer for U.S. Stem Cell about an intra-articular injection for the treatment of osteoarthritis in the latest issue of the Journal of Translational Medicine.

A paper co-authored by Kristin Comella’s, chief science officer for U.S. Stem Cell (OTCQB:USRM) about an intra-articular injection for the treatment of osteoarthritis in the latest issue of the Journal of Translational Medicine.
As quoted in the press release:

Comella is a world-renowned expert on regenerative medicine with a focus on adipose derived stem cells. She was named number 24 on Terrapin’s list of the Top 50 Global Stem Cell Influencers and number 1 on the Academy of Regenerative Practices list of Top 10 Stem Cell Innovators. Comella has pioneered stem cell therapies from various sources including cord blood, bone marrow, muscle, and adipose.
Entitled, “Intra-articular injection in the knee of adipose derived stromal cells (stromal vascular fraction) and platelet rich plasma for osteoarthritis,” the scientific paper was co-authored by Kristin Comella, Himanshu Bansal, Jerry Leon, Poonam Verma, Diwaker Agrawal, Prasad Koka and Thomas Ichim. Below is a link and abstract to the paper: http://bit.ly/2smaM93.

Click here to read the full press release.

Source: www.accesswire.com

MARKETS

Markets
TSX18861.36-217.28
TSXV617.26-9.08
DOW31097.26+321.83
S&P 5003825.33+39.95
NASD11127.85+99.11
ASX6539.90-28.20

COMMODITIES

Commodities
Gold1810.63+2.22
Silver19.86+0.01
Copper3.58-0.13
Palladium1944.00-1.00
Platinum888.50+2.50
Oil108.77+3.01
Heating Oil3.95+0.12
Natural Gas5.67+0.04

DOWNLOAD FREE REPORTS

×